Press Releases
GeNeuro Confirms Potential of Novel pHERV-K Antibodies for ALS in collaboration with NINDS, Secures Rights
GeNeuro , a biopharmaceutical company developing new treatments for neurological and autoimmune diseases, announced that following a successful collaboration in preclinical amyotrophic lateral sclerosis (ALS) models. The Company has signed an exclusive worldwide license with the...
Press Releases
Clinerion and S4 Research partner to accelerate the introduction of innovative medical treatments to India
Clinerion and S4 Research announce a partnership to expand the global network of hospitals on the Clinerion’s Patient Network Explorer platform into India. International pharmaceutical companies will be able to match their leading-edge clinical trials to patients in India....
Press Releases
LED SpA specifies THERMOLAST M from KRAIBURG TPE for lightweight, ergonomic and reusable SURGEON Pencil S
Specializing in the design and production of premium medical electronic equipment, LED SpA has added an innovative handpiece for use in high-frequency surgery to its portfolio. The SURGEON Pencil S provides a number of outstanding features...
Press Releases
Tjoapack and Veratrak launch EPOCH initiative
Global contract packaging and supply chain organisation (CPO), Tjoapack and UK-based technology company, Veratrak, have launched the European Platform on Changing Healthcare (EPOCH) as part of their ongoing partnership dedicated to improving pharmaceutical supply chain operations. ...
Press Releases
Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access
Sandoz, a Novartis division and the global leader in biosimilars, announced a global resolution of all intellectual property (IP) related litigation with AbbVie concerning the proposed Sandoz biosimilar Hyrimoz® (adalimumab) for reference medicine Humira®** (adalimumab). "In...
Press Releases
Almac Group Invests in Cutting Edge Next Generation Sequencing Capabilities for Bio Pharma Clients
Almac Diagnostic Services, a global stratified medicine company specialising in biomarker driven clinical trials, has made a significant investment in a new Illumina NovaSeq 6000 sequencer which will benefit Biopharma clients’ biomarker discovery and clinical trial projects. ...
Press Releases
FDA approves Roche’s Hemlibra for haemophilia A without factor VIII inhibitors
Roche announced that the US FDA has approved Hemlibra® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with haemophilia A without factor VIII inhibitors. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read